Category: ROOT

Shingles infection increases risk of heart attack, stroke

Researchers from Boston-based Brighams and Women’s Hospital found shingles led to an almost 30 percent higher risk of major cardiovascular events over 12 years.

Hawaii hospital marketing chief appointed to incoming governor’s staff

Makana McClellan, the director of marketing and business development for Honolulu-based Shriners Children’s Hawaii, has been appointed to the staff of incoming Hawaii Gov. Josh Green, MD.

Viewpoint: Health systems ‘gouging’ Americans with anti-competitive practices

Hospitals and health systems are “gouging” Americans with their anti-competitive behaviors, and more steps must be taken to reverse such policies, especially at a time of rising inflation and economic pressures, experts said in a Nov. 28 opinion piece …

ChristianaCare business unit to market surgeries, services to employers

Newark, Del.-based ChristianaCare has launched a business unit to market surgeries, products and services directly to employers around the U.S., the Philadelphia Business Journal reported Nov. 23. 

UW Health not required to recognize union, board rules

The Wisconsin Employment Relations Commission has issued an opinion that the University of Wisconsin Health in Madison is not required to recognize the nurses’ union and collectively bargain a contract under state law.

Legacy Health says former employee stole patient information

A former lab employee of Portland, Ore.-based Legacy Health stole patients’ personal and medical information, the health system said in a notice on its website.

70% of US reports high or very high flu activity: 8 FluView notes

Thirty-five states and regions are now reporting “high” or “very high” flu activity levels, according to the CDC’s latest FluView report.

FDA probes severe hypocalcemia risk with Amgen’s osteoporosis drug

The FDA will investigate the risk of severe hypocalcemia that results in hospitalization and death with Amgen’s osteoporosis drug, Prolia (denosumab). 

Second study participant dies during Eisai’s Alzheimer’s drug trial

A second study participant has died possibly as a result of the experimental antibody drug, lecanemab, meant to treat Alzheimer’s, Science reported Nov. 27.

5 hospitals seeking CEOs

Here are five hospitals and health systems that recently posted job listings seeking CEOs.